DICE Therapeutics, Inc.(DICE)_个股概要_股票价格_最新资讯_行情走势_历史数据

DICE Therapeutics, Inc.(DICE)

47.55+0.000.00%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
- 第27届DICE游戏奖提名名单公布，《漫威蜘蛛侠2》以9项提名领跑
  ZOL中关村在线 · 01-11
  第27届DICE游戏奖提名名单公布，《漫威蜘蛛侠2》以9项提名领跑
- 六合宁远创业板IPO上会在即：实控人股权转让款“间接流向”客户能否过关
  华尔街见闻 · 2023-11-22
  六合宁远创业板IPO上会在即：实控人股权转让款“间接流向”客户能否过关
公司概况
公司名称
DICE Therapeutics, Inc.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.dicemolecules.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
DICE Therapeutics, Inc.于2013年8月14日在特拉华州注册成立。该公司是一家生物制药公司，利用其专有的技术平台建立一系列新型口服治疗药物，以治疗免疫学和其他治疗领域的慢性病。该公司最初专注于针对免疫学中经过充分验证的靶点开发口服疗法，目标是实现与全身生物学对应物相同的效果，后者已证明迄今为止在这些疾病领域中具有最大的治疗益处。
- 2023-08-09
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2023-08-09
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2023-08-09
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2023-08-09
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2023-08-09
  交易所摘牌声明
  Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
- 2023-08-09
  超过5%披露
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
- 2023-08-08
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2023-06-23
  超过5%披露
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
- 2023-06-23
  超过5%披露
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
- 2023-06-21
  超过5%披露
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
- 2023-06-20
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2023-06-07
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2023-05-11
  季度报告
  10-Q - Quarterly report [Sections 13 or 15(d)]
  10-Q - Quarterly report [Sections 13 or 15(d)]
- 2023-05-11
  重要事件披露
  8-K - Current report
  8-K - Current report
- 2023-05-05
  关联方拟减持公告
  144 - Report of proposed sale of securities
  144 - Report of proposed sale of securities